|
Tumor suppression, p53 and retrotransposons
|
1R01CA222579-01
|
$370,575
|
ABRAMS, JOHN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Li-Fraumeni Syndrome in Brazil
|
ZIA CP010144 10769
|
$53,072
|
Achatz, Maria Isabel
|
DCEG (NCI)
|
|
Identifying molecular drivers of tumor heterogeneity in pancreatic cancer
|
1F31CA224792-01A1
|
$36,672
|
ADAMS, CHRISTINA
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer
|
5K08CA218420-02
|
$177,120
|
AGUIRRE, ANDREW
|
DANA-FARBER CANCER INST
|
|
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.
|
5R01CA133379-10
|
$381,375
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Genetic Dissection of Acute Myeloid Leukemia.
|
5R01CA169784-05
|
$355,993
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Long non-coding RNAs in hematopoiesis and blood malignancy
|
5R01CA194923-04
|
$457,533
|
AIFANTIS, IANNIS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Initiation of DNA Replication in Mammalian Cells
|
ZIA BC 010411
|
$1,096,129
|
Aladjem, Mirit
|
CCR (NCI)
|
|
p63 as a novel factor promoting pregnancy-induced HER2-positive breast cancer
|
5K22CA190653-03
|
$157,743
|
ALEXANDROVA, EVGUENIA
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Oncogenic Disruption of the Circadian Metabolic Cycle in Cancer
|
4R00CA204593-03
|
$249,000
|
ALTMAN, BRIAN
|
UNIVERSITY OF ROCHESTER
|
|
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence
|
3R01CA208042-03S1
|
$223,893
|
ALVAREZ, JAMES
|
DUKE UNIVERSITY
|
|
Par-4 Regulation and Function in Breast Cancer Dormancy and Recurrence
|
5R01CA208042-03
|
$363,713
|
ALVAREZ, JAMES
|
DUKE UNIVERSITY
|
|
Molecular mechanisms of BRAF inhibitor induced UPR and autophagy
|
5R01CA198015-04
|
$366,000
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Non-coding RNAs as Prognostic and Diagnostic Markers in Prostate Cancer
|
ZIA BC 010886
|
$49,970
|
Ambs, Stefan
|
CCR (NCI)
|
|
Role of histone kinase VprBP in gene silencing: mechanisms, targets, and regulation
|
5R01CA201561-03
|
$377,438
|
AN, WOOJIN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Nuclear Factor-kappaB in Ovarian Cancer
|
ZIA BC 011054
|
$480,705
|
Annunziata, Christina
|
CCR (NCI)
|
|
Collaborative Pathways that Lead to Leukemia
|
ZIA BC 010982
|
$437,122
|
Aplan, Peter
|
CCR (NCI)
|
|
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
|
ZIA BC 010983
|
$374,676
|
Aplan, Peter
|
CCR (NCI)
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$374,676
|
Aplan, Peter
|
CCR (NCI)
|
|
FOXD3 up-regulation and ERBB3 signaling as an adaptive response to BRAF inhibitors in melanoma
|
2R01CA160495-06A1
|
$370,500
|
APLIN, ANDREW
|
THOMAS JEFFERSON UNIVERSITY
|
|
Tumor Suppressor Protein, p53
|
ZIA BC 005599
|
$388,703
|
Appella, Ettore
|
CCR (NCI)
|
|
Regulation and Function of WIP1 Phosphatase and its Role in Tumor Cells
|
ZIA BC 011197
|
$583,055
|
Appella, Ettore
|
CCR (NCI)
|
|
Targeting the TGIF/Twist1 network in osteosarcoma
|
5R01CA210911-02
|
$348,844
|
ATFI, AZEDDINE
|
UNIVERSITY OF MISSISSIPPI MED CTR
|
|
Integrative approaches to elucidate p53 transcriptional networks during carcinogenesis
|
5R35CA197591-04
|
$977,640
|
ATTARDI, LAURA
|
STANFORD UNIVERSITY
|
|
Role of the Long Non-coding RNA PVT1 in Cancer
|
5R01CA200643-03
|
$446,063
|
BAGCHI, ANINDYA
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
Normal and Neoplastic Growth in the Brain
|
5P01CA096832-14
|
$1,999,508
|
BAKER, SUZANNE
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
c-Met-induced Renalase: a novel therapeutic target for renal cancer
|
1R03CA219731-01A1
|
$88,500
|
BALAN, MURUGABASKAR
|
BOSTON CHILDREN'S HOSPITAL
|
|
IKK/NF-kappaB Signaling in Cancer: Therapy, Resistance, and Tumor Initiating Cells
|
5R35CA197684-03
|
$848,325
|
BALDWIN, ALBERT
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Characterizing the resistance mechanisms to BET-bromodomain inhibition in MYC-amplified medulloblastoma
|
4R00CA201592-03
|
$249,000
|
BANDOPADHAYAY, PRATITI
|
DANA-FARBER CANCER INST
|
|
Oncogenic Ras-induced macropinocytosis: A new paradigm for metabolic adaptation
|
5R35CA210263-03
|
$968,501
|
BAR-SAGI, DAFNA
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
A-to-I microRNA Editing and Melanoma Metastasis
|
1R21CA219958-01A1
|
$208,800
|
BARELI, MENASHE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
FOXM1-RHNO1 Oncogenic Axis in Ovarian Cancer
|
4K00CA212470-03
|
$71,280
|
BARGER, CARTER
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Tumor Suppression by an African Specific Variant of p53
|
1F32CA220972-01A1
|
$59,038
|
BARNOUD, THIBAUT
|
WISTAR INSTITUTE
|
|
Studies of amplification in rhabdomyosarcoma
|
ZIA BC 011378
|
$358,849
|
Barr, Frederic
|
CCR (NCI)
|
|
Studies of gene fusions in rhabdomyosarcoma
|
ZIA BC 011387
|
$410,113
|
Barr, Frederic
|
CCR (NCI)
|
|
The roles of TRIM24 in breast cancer
|
5R01CA214871-02
|
$402,021
|
BARTON, MICHELLE
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Novel Roles for Oncogenic SOX2 in Esophageal Squamous Cell Carcinoma
|
5R01CA187119-04
|
$384,872
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
ARHI (DIRAS3) in Autophagy and Dormancy of Ovarian Cancer
|
5R01CA135354-08
|
$380,000
|
BAST, ROBERT
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Systems-level analysis of the regulation and function of p53 dynamics
|
ZIA BC 011382
|
$379,473
|
Batchelor, Eric
|
CCR (NCI)
|
|
Systems-level analysis of the regulation and function of MYC
|
ZIA BC 011487
|
$162,631
|
Batchelor, Eric
|
CCR (NCI)
|
|
RNF128 Regulation of TP53 in Barretts Progression
|
5R01CA215596-02
|
$422,751
|
BEER, DAVID
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The role of AXL-ABL axis in Barretts carcinogenesis
|
3R01CA193219-04S1
|
$58,182
|
BELKHIRI, ABBES
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
The role of AXL-ABL axis in Barretts carcinogenesis
|
5R01CA193219-04
|
$361,425
|
BELKHIRI, ABBES
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Linking Oncogenic Signaling to Tumor Metabolism
|
5R00CA194192-04
|
$230,670
|
BEN-SAHRA, ISSAM
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Epigenetic regulation by tumor suppressor p53
|
3R01CA078831-19S1
|
$54,452
|
BERGER, SHELLEY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Investigating the role of the small GTPase RIT1 in lung adenocarcinoma
|
5R00CA197762-04
|
$249,000
|
BERGER, ALICE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Epigenetic regulation by tumor suppressor p53
|
5R01CA078831-19
|
$352,848
|
BERGER, SHELLEY
|
UNIVERSITY OF PENNSYLVANIA
|
|
Characterizing TP53 and PPM1D mutations as resistance drivers to radiation therapy in Diffuse Intrinsic Pontine Gliomas
|
5R01CA219943-02
|
$507,552
|
BEROUKHIM, RAMEEN
|
BROAD INSTITUTE, INC.
|
|
Development of Natural Product Leads as Anticancer Therapeutics
|
ZIA BC 011470
|
$330,596
|
Beutler, John
|
CCR (NCI)
|
|
Ubiquilin1 regulates EMT and metastasis of human lung adenocarcinoma
|
3R01CA193220-04S2
|
$39,768
|
BEVERLY, LEVI
|
UNIVERSITY OF LOUISVILLE
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|